Hege Lei of China (Dalian) Pharmaceutical Co., Ltd. and Canadian URO Technology Co., Ltd. today signed contracts, mergers and acquisitions all of its assets and technology, digital thermometer the mainland's first acquisition of a medical device company's country of foreign private enterprises.
Zhe Qin, general manager of the company at the signing ceremony, clinical thermometer said in a four plus two enterprises participated in the merger competition. ear thermometer To avoid legal risks, to take the asset acquisitions, purchased the company's patented and proprietary technology, government permits, trademarks, equipment,digital blood pressure monitor inventory and all other valuable assets.
He pointed out that Canada URO R & D of digital monitoring system in China on the bladder is still a technical gap, this acquisition will boost China's digital medical equipment products to the developed countries of the mainstream market. The system uses a bladder degree of hemodynamic and oxygen saturation monitoring can ensure that the clinical diagnosis of non-invasive, easy to operate and effectively reduce costs, is expected to gradually replace the traditional invasive procedures, has important clinical significance.
According to reports, the digital monitoring system is currently the bladder European Union and Canada have been certified by the Ministry of Health and was approved by U.S. sales last year. The system has 8 patents, technology, real-time measurement, evaluation of bladder function, to achieve non-invasive diagnosis of bladder obstruction. As of now the Netherlands, Canada, South Korea signed a distribution agreement.
Experts said that in recent years, the rising incidence of prostate disease, annual global emerging more than 1 million cases of prostate cancer. Mainland China prostatic hyperplasia and other diseases about substantial growth in more than 8,000 people, including younger patients with chronic prostatitis showed significant trends.